Specific IgE and IgG antibody-binding patterns to recombinant cockroach allergens - 18/08/11
Charlottesville, Va
Abstract |
Background |
The specificity of serum antibody responses to different cockroach allergens has not been studied.
Objective |
We sought to quantitate serum IgE and IgG antibodies to a panel of purified cockroach allergens among cockroach-sensitized subjects.
Methods |
IgE antibodies to recombinant cockroach allergens (rBla g 1, rBla g 2, rBla g 4, rBla g 5, and rPer a 7) were measured in sera containing IgE antibodies to Blattella germanica extract (n=118) by using a streptavidin CAP assay and a multiplex flow cytometric assay. Specific IgG antibodies were determined by using radioimmunoprecipitation techniques.
Results |
Specific IgE antibodies measured by means of CAP assay and multiplex assay were strongly correlated (r=0.8, P < .001). The sum of IgE antibodies (in international units per milliliter) against all 5 allergens equated to IgE antibodies to cockroach extract. Although the prevalence of IgE antibodies was highest for rBla g 2 (54.4%) and rBla g 5 (37.4%), patterns of IgE antibody binding were unique to each subject. Surprisingly, only 16% of cockroach-sensitized subjects with IgE antibodies to house dust mite exhibited IgE antibody binding to cockroach tropomyosin (rPer a 7). Specific IgE antibodies were associated with increased IgG antibody levels, although detection of IgG in the absence of IgE was not uncommon.
Conclusion |
The techniques described offer a new approach for defining the hierarchy of purified allergens. IgE antibodies directed against 5 allergens constitute the majority of the IgE antibody repertoire for cockroach. Such distinct patterns of IgE-IgG responsiveness to different cockroach allergens highlight the complexity of B-cell responses to environmental allergens.
Le texte complet de cet article est disponible en PDF.Key words : Cockroach, asthma, allergens, tropomyosin, IgE antibody, IgG antibody, multiplex
Abbreviations used : HDM, RIA
Plan
Supported by National Institutes of Health grant AI-20565, and grants from Indoor Biotechnologies, Inc, and from Philip Morris Inc (to A. Pomés and M. D. Chapman). |
Vol 115 - N° 4
P. 803-809 - avril 2005 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?